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Abstract.  Vertebrate muscles are composed of an ar- 
ray of diverse fast and slow fiber types with different 
contractile properties. Differences among fibers in fast 
and slow MyHC expression could be due to extrinsic 
factors that act on the differentiated myofibers. Alter- 
natively, the mononucleate myoblasts that fuse to form 
multinucleated muscle fibers could differ intrinsically 
due to lineage. To distinguish between these possi- 
bilities, we determined whether the changes in propor- 
tion of slow fibers were attributable to inherent differ- 
ences in myoblasts. The proportion of fibers expressing 
slow myosin heavy chain (MyHC) was found to change 
markedly with time during embryonic and fetal human 
limb development. During the first trimester, a maxi- 
mum of 75 % of fibers expressed slow MyHC. There- 
after, new fibers formed which did not express this 
MyHC, so that the proportion of fibers expressing slow 
MyHC dropped to "~3 % of the total by midgestation. 
Several weeks later, a  subset of the new fibers began 
to express slow MyHC and from week 30 of gestation 
through adulthood, ~50%  of fibers were slow. How- 
ever, each myoblast clone (n  =  2,119)  derived from 
muscle tissues at six stages of human development 
(weeks 7, 9,  16, and 22 of gestation, 2 mo after birth 
and adult) expressed slow MyHC upon differentiation. 
We conclude from these results that the control of slow 
MyHC expression in vivo during muscle fiber forma- 
tion in embryonic development is largely extrinsic to 
the myoblast. By contrast, human myoblast clones 
from the same samples differed in their expression of 
embryonic and neonatal MyHCs, in agreement with 
studies in other species, and this difference was shown 
to be stably heritable. Even after 25 population dou- 
blings in tissue culture, embryonic stage myoblasts did 
not give rise to myoblasts capable of expressing 
MyHCs typical of neonatal stages, indicating that 
stage-specific differences are not under the control of a 
division dependent mechanism, or intrinsic "clock." 
Taken together, these results suggest that, unlike em- 
bryonic and neonatal MyHCs, the expression of slow 
MyHC in vivo at different developmental stages dur- 
ing gestation is not the result of commitment to a dis- 
tinct myoblast lineage, but is largely determined by the 
environment. 
ULT skeletal muscles of  humans are heterogeneous  tis- 
sues. Limb muscles have a characteristic proportion 
and spatial arrangement of type I (slow-twitch) and 
type IIA and type liB (fast-twitch) fibers  (for review, see 
Schmalbruch, i985). This arrangement of fiber types is re- 
sponsible for the unique contractile properties of the muscle 
as a whole. In adult muscle, fiber-type classifications have 
been established by correlation of physiological, biochemi- 
cal and histochemical properties (for review, see Schmal- 
bruch,  1985). By contrast, in embryonic muscle, the bio- 
chemical  and  histochemical properties  of fibers  do  not 
correlate and fiber typing has been problematic  (Guth and 
Samaha, 1972). Recently, this problem was overcome by the 
development of immunological reagents.  Especially  useful 
are mAbs to myosin heavy chains (MyHCs).~ MyHCs are 
largely responsible  for the ATPase activity, and therefore 
contraction rate,  of individual  fibers.  In particular,  anti- 
bodies have had a major impact on studies of fiber develop- 
ment, because they can distinguish  developmentally-regu- 
lated neonatal and adult fast myosins  in the presence of 
embryonic isoforms (Schiatfino et al., 1982; Webster et al., 
1988b). As a result, immunohistochemistry  now permits an 
analysis of the basis for fiber-type heterogeneity and pattern 
formation during embryogenesis. 
Myosin is a multimeric complex of two heavy chains and 
four light chains.  Both the heavy and light chains  are en- 
coded by multigene families. The heavy chains, which con- 
tain the ATPase activity of  the myosin complex, are a diverse 
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fiber-type  specific isoforms (Whalen et al.,  1981; Wydro et 
al., 1983; Leinwand et al., 1983; Saez and Leinwand,  1986; 
Weydert et al., 1987). The heavy chain composition of skele- 
tal muscle fibers changes throughout development. The cel- 
lular and molecular basis for these changes in gene expres- 
sion and how they result in the ultimate pattern of fiber types 
in individual muscles is unclear. 
In particular,  the  cellular  origin  of specialized  muscle 
fibers with different contractile properties remains unknown. 
Two hypotheses are that (a) myoblasts that form the fast and 
slow fibers are distinct and their intrinsic properties confer 
a specific pattern of gene expression on the multinucleated 
fibers they form upon cell fusion, or (b) myoblasts are simi- 
lar and extrinsic factors induce a specific pattern of gene ex- 
pression on the differentiated  multinucleate  muscle fibers 
they form. In support of the first hypothesis,  analyses of cul- 
tured myoblasts isolated from the limb buds of chick (Miller 
and Stockdale,  1986a,b) and mouse (Vivarelli et al.,  1988) 
embryos distinguished populations of myoblasts that differed 
in their expression of slow and fast MyHCs.  These results 
led to the proposal that myoblasts are committed to fast and 
slow fiber-type lineages which are responsible  for the devel- 
opment of fiber-type  diversity. 
Here, in support of the second hypothesis, we provide evi- 
dence that the expression of fast and slow MyHCs in newly 
formed secondary fibers is not due to the intrinsic potential 
of myoblasts but is determined  by their  environment.  We 
show that there are marked differences  in the proportion of 
fibers expressing slow MyHC in muscle tissue at different 
stages  of  human  embryonic  development.  To  determine 
whether  these  differences  reflect  properties  of  myoblast 
populations, we tested the intrinsic capacity of human myo- 
blasts to express slow MyHC when isolated from muscle of 
six developmental stages,  ranging  from week 7 of human 
gestation to adult. The results show that, although myoblasts 
are heterogeneous with respect to the expression of stage- 
specific MyHC isoforms, these differences  do not account 
for functionally distinct fast and slow fiber types. Thus, myo- 
blasts may differ in their potential to express embryonic and 
neonatal MyHC isoforms, but all myoblasts at all stages are 
capable of expressing slow MyHC isoforms upon differentia- 
tion in vitro. 
What regulates the expression of fast and slow MyHC ex- 
pression in vivo? From mid-gestation on, the phenotype of 
preexisting  fibers into which myoblasts fuse is likely  to be 
the major determinant (Hughes and Blau,  1992). However, 
dominance of preexisting  fibers cannot explain the observa- 
tions at earlier stages.  Before and at the time when the first 
fast fibers are forming (week 10 of gestation), all myoblasts 
are capable of expressing slow MyHC.  Thus, we conclude 
that the lack of expression of slow MyHCs in the earliest- 
forming fast muscle fibers in vivo is largely determined by 
the environment. 
Materials and Methods 
Cell Culture 
Cells were isolated from human skeletal muscle as described previously 
(Blau and Webster,  1981).  All samples were  from individuals with no 
known myopathies  or other abnormalities affecting muscle development. 
Muscle samples were from the vastus lateralis muscle, with the exception 
of the youngest stages of development (weeks 7-9) for which the entire thigh 
was used. Muscles from six developmental time points were analyzed:  em- 
bryonic (three samples each at weeks 7 and 9 of gestation), fetal (weeks 16 
and 22 of gestation), neonatal (2 mo after birth), and adult (2.5 yr after 
birth). Muscle from individuals 2 yr or older is defined as adult because 
it is fully developed with respect to fiber type. At week 7 and week 9, tissue 
samples from three different individuals were analyzed in each case. Em- 
bryonic and fetal muscles were obtained subsequent to therapeutic abor- 
tion, postnatal muscles at autopsy, and adult muscles consequent to correc- 
tive orthopedic surgery. All samples were procured in accordance with the 
guidelines of the Stanford Human Subjects  Committee. 
For clonal analysis,  cells were grown as previously  described (Webster 
et al., 1988a).  Briefly, cells were plated at '~1 cell/era  2 in a 1:1 mixture of 
fresh and conditioned growth medium (GM: Ham's nutrient mixture F-10 
with 15% FBS (Hyclone Laboratories, Inc., Logan, UT), 0.5% chick em- 
bryo  extract  (GIBCO)  and  1%  penicillin/streptomycin [GIBCO  BRL, 
Gaithersburg, MD]). Conditioned medium was harvested from adult human 
muscle cultures and filtered through a 0.2 #m filter (Nalge Co., Rochester, 
NY) before use.  Dishes were precoated with a solution of type I collagen 
(0.15 % calf skin collagen, Sigma Chemical Co., St. Louis, MO). When the 
majority of colonies contained ,~103 cells ('~10 d after plating), cultures 
were switched to fusion medium (FM: DME with 5% horse serum [Hy- 
clone Laboratories],  10  -6 M  bovine insulin [Sigma  Chemical Co.]  and 
10  -6 M  dexamethasone [Sigma  Chemical Co.]) and thereafter fed every 
2 d with FM until analysis.  For some experiments,  0.5 % chick embryo ex- 
tract was included in the FM, but this did not change the results. 
Monoclonal Antibodies 
Mice were immunized by subcutaneous injection of partially purified fetal 
(week 15 of gestation; antibodies FI.652, F1.188), neonatal (day 5 postnatal; 
antibody N3.36) or adult (21 year; antibody A4.951, previously referred to 
as 4A.951)  human skeletal muscle myosin preparations and hybridomas 
produced 3 d later,  as previously described (Silberstein and Blau,  1986). 
Clones were screened for production of antibodies that reacted with MyHC 
in ELISA,  specifically  labeled subpopulations of human skeletal  muscle 
fibers in immunofluorescence  assays  on tissue sections (Webster et al., 
1988b) and reacted with a 220-kD MyHC band on Western blots of the im- 
munogen (data not shown). In addition, the antibodies were shown to react 
with specific MyHCs separated on high resolution gels and with peptides 
encoded by specific  cDNAs  2 (Hughes  et al.,  1993).  All antibodies are 
available  from American Type Culture Collection (Rock'vllle, MD). 
Extraction of  MyHCs  from Human Muscle Tissues 
MyHCs were extracted from human muscle tissue essentially  as described 
in Whalen et al. (1984).  Briefly, 50-200 mg of frozen muscle tissue was 
weighed and minced with scissors for 4-5 min in four times the tissue 
weight of a high salt buffer with 0.1%/~-mercaptoethanol  ~-ME) and pro- 
tease inhibitors (20 mg/rul trypsin inhibitor, 0.1 mM pepstatin A and 0.1 
mM leupeptin). After 20--40 rain of extraction on ice, debris was removed 
by centrifugation at 13,000 g for 30 min at 4°C. Supcrnatants were diluted 
10-fold in a low salt buffer with 0.1% E-ME and protease inhibitors and in- 
cubated overnight on ice. Precipitated MyHCs were pelleted by centrifnga- 
tion at  13,000  g  for 30 rain and resnspended in 0.5  M  NaCI/10  mM 
NaPO4, pH 7.0 with protease inhihitors and allowed to dissolve overnight 
on ice.  Samples were then boiled for three min in Laemmii SDS sample 
buffer and stored in 10-ml aliquots  at -80°C for up to 3 mo. 
High-resolution SDS-Glycerol  PAGE  and Western 
Blotting of  MyHC Extracts 
MyHCs were separated by SDS/glycerol PAGE essentially  as described by 
LaFramboise et el. (1990) but with modifications  for optimal resolution of 
human isoforms.  Samples  were electrophoresed through a 3 % polyacryl- 
amide stacking gel and 5.5% polyacrylamide,  35% glycerol separating gel 
for 22-24 h at 15°C, constant voltage (80 V through stacking gel,  160 V 
through separating gel) in a Tris-glycine buffer system (pH &3). Stock solu- 
tions of acrylamide contained 28.5%  acrylamide (Bio-Rad Laboratories, 
Richmond, CA) and 1.5 % bis-acrylamide (Bio-Rad Laboratories), Portions 
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Laboratories)  or transferred  to polyvinylidene  fluoride (PVDF) membrane 
(Immobilon-P; Millipore Corp., Bedford, MA). 
For Western blot analysis, proteins were transferred  in 10 mM 3-[cyclo- 
hexylamino]-l-propanesulfonic acid (CAPS, Sigma Chemical Co.), 5% 
methanol for 1648 h at 4"C at constant  current (50 mA). Membranes  were 
blocked for 2-4 h in blocking  buffer  (PBS, 0.02% sodium azide, 5% horse 
serum (HS), 5 % nonfat  dry milk) and air dried at room  temperature  befiare 
antibody  staining. Tissue  culture supernatants from  mouse  hybridomas  pro- 
dueing antibodies specific  for MyHCs were  diluted 1:3 or 1:4 in blocking 
buffer immediately  before incubating with membranes  for 1-2 h at room 
temperature. Membranes  were washed three times in PBS, 0.05  % Tween- 
20, incubated with peroxidase-conjngated  goat anti-mouse  secondary  anti- 
bodies F(ab)2 anti-IgG  or anti-IgM, Cappel Laboratories  (Malvern, PA); 
diluted 1:1,000 in PBS, 0.02% sodium  azide, 5% HS) for I h at room  tem- 
perature, and washed again, as described above. Proteins detected by the 
antibodies were  visualized  by incubation  of  the membranes  with ECL lumi- 
nescent peroxidase  substrate (ECL, Amersham  Corp., Arlington Heights, 
IL) for one minute and exposure  to x-ray  film (XAR-5, Kodak)  until bands 
were visible (1 s-1 rain). Subsequently, all MyHC isoforms  bound to the 
membranes  could be detected by staining  with  antibody  A4.1025 and perox- 
idase-anti-IgG, followed  by visualization with the ECL substrate. 
Immunofluorescence 
For immunohistochemistry, fresh tissue was mounted in OCT mounting 
medium (Baxter Scientific Products,  McGaw Park, IL) and frozen in melt- 
ing isopentane (Sigma Chemical Co.).  Tran,werse 8-/~m cryostat sections 
were placed on gelatin-coated slides and stored desiccated at -20°C until 
staining. Cultured cells were fixed and stained with mAbs as described pre- 
viously (Sflberstein  et al.,  1986). For these studies,  the following  1:1 mix- 
tures of IgG- and IgM-containing supernatants were used:  A4.951 (IgG) 
and F1.188 (IgM) or F1.652 (IgG) and N3.36 (IgM). Secondary antibodies 
were conjugated either to fluorescein (goat anti-mouse IgG, Cappel Labora- 
tories) or to rhodamine (goat anti-mouse IgM, Cappel Laboratories). Cells 
were examined with a Leitz epi-fluorescence  Orthoplan microscope using 
fiuorescein-specific  (excitation 470-490 urn) and rhodamine-specilic (exci- 
tation 530-560 urn) optical filters and a 25× objective.  Photographs were 
taken with Kodak Tri-X film using a Leitz Vario-Orthomat E camera. 
Results 
Myoblasts  from All Stages Express Slow MyHCs 
upon Differentiation 
Slow MyHC is Recognized by Antibody ,44.951. We deter- 
mined the pattern of slow MyHC expression in primary and 
secondary human muscle fibers in vivo with a mAb, A4.951. 
The specificity of this antibody has been extensively charac- 
terized (Hughes et aL,  1993).  Briefly, A4.951  exclusively 
recognizes a 220-kD protein in Western blots of whole-cell 
lysates of cultured  human  myotubes,  indicating  that  it  is 
specific for the heavy chain of myosin. Furthermore, A4.951 
recognizes a MyHC which migrates at the type I position in 
Western blots of  high-resolution SDS-polyacrylamide gels in 
which types I, IIa, and Ub MyHCs of adult skeletal muscle 
can be resolved (Klitgaard et al.,  1990).  A  similar band of 
mobility specific to type I is evident on blots of extracts of 
muscle at all stages analyzed: tissues from weeks 14 (Hughes 
et al.,  1993) and 22 of gestation,  adult muscle, and in ex- 
tracts of cultured human myotubes (Fig.  1). This is true also 
when MyHCs of earlier stages were analyzed by Western 
blot of denaturing gels (Hughes et al.,  1993).  In addition, 
A4.951  has been shown to recognize the head domain of 
human  b-cardiac/slow  MyHC  expressed  from  a  eDNA 
(Hughes et al., 1993). Finally, expression of A4.951-reactive 
myosin has  been correlated  with  slow ATPase activity in 
serial frozen sections of adult muscle tissue (Webster et al., 
1988b). Therefore, by numerous criteria, A4.951 recognizes 
a  slow MyHC present in human muscle development. 
F1.188 (Control) Recognizes Prenatal MyHCs  in All 
F/hers. Antibody F1.188 reacts with MyHC in muscle tissue 
and  in  cultured  muscle ceils.  It reacts uniformly with  all 
fibers in frozen sections of human muscle tissue, including 
fast and slow,  primary and secondary, and cultured muscle 
cells  from  samples  at all  stages  of prenatal  development 
(data not shown). F1.188  recognizes either an epitope com- 
mon to all MyHCs or a MyHC isoform that is prevalent in 
all fibers at all stages of prenatal development. Thus, F1.188 
serves as a  useful control,  as a  marker of the presence of 
MyHC at any given point in gestation or in cultured cells. 
Slow MyHC is Expressed in Two Phases During Human 
Embryogenesis, An analysis of slow MyHC in tissue sec- 
tions  revealed  that  the  proportions  of slow  fibers  change 
markedly during human embryonic development (Fig.  2). 
At  8  wk of gestation,  widely-separated clusters  of small- 
diameter  fibers  with  central  nuclei  are  interspersed  with 
mononuclear cells and connective tissue (Fidzianska, 1980a 
and Fig. 2 a). Myofibers can be identified by their expression 
of embryonic MyHC, as detected by antibody F1.652  (see 
Fig. 6 a). Although all myofibers at this stage of development 
express embryonic MyHC, none react with A4.951 (Fig. 2 h). 
By 10 wk of gestation, A4.951+  slow MyHC is first ex- 
pressed, in the vast majority of fibers (Fig.  2  i).  A4.951+ 
MyHC is expressed most strongly in the largest diameter pri- 
Figure 1. A4.951  recognizes slow MyHC in hu- 
man muscle tissue and cultures. Extracts of  human 
thigh muscle at week 22 (wk 22) of  gestation, adult 
human muscle cultures differentiated in culture for 
1 wk (/wk) 2 wk (2 wk) or three wk (3 wk) and 
adult human diaphragm tissue (Ad) were electro- 
phoresed  through  high-resolution  glycerol/SDS 
5.5%  polyacrylamide  gels.  One  set  of samples 
was  silver  stained  (left) and  two  identical  sets 
were transferred to PVDF membrane.  Individual 
panels of membrane were reacted with antibodies 
as described in Materials and Methods. The posi- 
tions of types I, IIa, and l]b MyHC are indicated, 
as defined by Klitgaard et al. (1990). A4.951 rec- 
ognizes slow MyHC in extracts of  both muscle tis- 
sue and cultures. 
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slow MyHC-expressing  fibers 
changes markedly during de- 
velopment.  Transverse  sec- 
tions of human limb muscle at 
weeks 8 (a, h), 10 (b, 0, 17 (c, 
j), 21 (d, k) 27 (e, l) and 30 
(f, m) of gestation, and 12 yr 
postnatal (g, n) were stained 
with antibody A4.951 (h-n) 
followed by  an  Frrc-conju- 
gated  goat  anti-mouse  IgG sec- 
ondary antibody. Phase con- 
trast  micrographs  (a-g)  are 
the same fields shown in im- 
munofluorescence (h-n),  a-e 
are also shown in Fig. 6. Bar, 
100 tLm. 
mary fibers, which are labeled with a characteristic ringlike 
pattern when viewed in cross-section because of the location 
of the nucleus in the center of the fiber.  Some fibers react 
weakly with A4.951, and are likely to be immature primary 
fibers because of their intermediate size and clearly visible 
central nuclei. The fibers that do not react with A4.951 are 
very small in diameter, and the location of the nuclei is un- 
clear, presumably because of their small size (Fig. 2 b), al- 
though their identity as muscle fibers is confirmed by their 
expression of embryonic MyHC (Fig. 6 b) and MyHC de- 
tected by antibody A4.1519. ~ 
Between weeks 10 and 21 of gestation, the proportion of 
fibers that reacts with A4.951 progressively declines (Fig. 2 
i-l, Table I). Although '~75 % of fibers present appear to ex- 
press A4.951+ MyHC at week 10 of gestation, by week 17, 
the  percentage  of fibers  expressing  this  isoform has  de- 
creased to '~10%.  By week 21, the maturation of primary 
fibers has progressed, as reflected by the absence of central 
nuclei (Fig. 2  k) and the loss of expression of embryonic 
MyHC (see Fig. 6 d). At this stage (midgestation), A4.951+ 
fibers comprise only 3 % of  total fibers, and are clearly larger 
than A4.951 fibers, indicating that at this stage, like earlier 
stages of development, slow MyHC expression is restricted 
to primary fibers. 
The decrease in the proportion of slow primary fibers be- 
tween week 10 and 21 of gestation can be accounted for by 
the dramatic increase in the numbers of secondary fibers 
during these stages (Fidzianska, 1980a), which express fast 
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Developing Human Muscle* 
Mean number  Percent 
Gestational  Mean number  A4.951-positive  A4.951-positive 
Stage~  total fibers/field§  (slow) fibers/field§  (slow) fibersn 
wk 
8  134 + 21  0 + 0  0%  :t: 0% 
I0  168 5:8  126 + 9  75% +  3.3% 
12  258 +  12  118:1:18  48% +  3.1% 
17  253 +  11  24 + 6  9.5%  +  1.8% 
21  261  +  17  8 + 4  3.1% +  1.1% 
27  651  + 25  23 +  8  3.5%  + 0.72% 
30  319 +  12  157 +  8  49%  + 2.8% 
2 postnatal  280 + 9  137 5:7  49%  +  3.0% 
adult  19 + 2  11  + 2  58% +  11% 
*Transverse sections of human muscle were reacted with antibody A4.951 and 
reactivity detected by immunofluorescence as described in the legend to Fig. 3. 
$ Three to five samples were analyzed at each developmental stage. 
§ Three to five separate microscopic  fields (10  -5 m2 each) were analyzed for 
each data point, with error calculated as SEM. Number of fibers have been nor- 
realized to unit area of 10  -5 m2. The increase in fiber number between weeks 
8 and 27 of gestation reflects an increase in fiber formation and density.  The 
decrease after week 27 reflects the growth of fibers and accompanying increase 
in diameter. 
II Error is calculated as the standard error of the proportion. 
MyHC. Over this period of  human muscle development, see- 
ondary fibers can be distinguished from the primary fibers 
by their smaller diameters.  We found that,  at week 27 of 
gestation,  the  mean  fiber diameter of the  large-diameter 
fibers is approximately twice that of the smaller-diameter 
fiber population (see Fig. 2 l), and that cross-sectional di- 
ameter distinguishes two populations of fibers with virtually 
nonoverlapping size distributions, a distinction that persists 
until approximately week 30 of gestation (Webster and Blau, 
unpublished results; Wohlfart,  1937). 
By week 27, A4.951+ MyHC is induced in a subset of sec- 
ondary fibers (Fig. 2 e and l). At this stage, primary fibers, 
which continue to express slow MyHC, are still distinguish- 
able by their greater diameters (Fig. 2 l). Over the next 3 wk, 
the percentage of total fibers expressing slow MyHC in- 
creases rapidly to ,,o50% of all fibers in the vastus lateralis. 
This is due to a conversion of some secondary fast fibers into 
slow fibers. The proportion of fast and slow fibers remains 
constant from that point onward and is typical of adult mus- 
cle (Fig. 2, f-g, m-n, Table I). Thus, the proportion of slow 
MyHC-expressing fibers in  human  muscle  changes  from 
75 % during the first trimester to a minimum of 3 % at mid- 
gestation and stabilizes around 50 % at 30 wk of gestation 
and beyond into adulthood. 
Slow MyHC is Expressed  in All Colonies of Cultured 
Myogenic Cells Irrespective of the Developmental Stage of 
the Source. To determine whether myoblasts are specialized 
for slow or fast fates, we examined whether the proportions 
of slow  MyHC-expressing myogenic clones  in  vitro cor- 
related with the proportions of slow expressing fibers in vivo. 
We hypothesized that the presence of slow MyHC in primary 
but not secondary fibers shortly after their formation was due 
to  an  intrinsic  difference  in  myoblasts  to  express  slow 
MyHC. To address this possibility, myoblasts were isolated 
from muscle tissues at a range of  developmental stages, from 
week 7  of gestation  to 2.5  yr after birth,  including  key 
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Iqgure 3. Time course of  slow MyHC expression in cultured human 
muscle cell colonies. Colonies were derived from muscle tissues 
of embryonic week 7 (n  =  165), week 9 (n  =  393),  week 16 
(n = 270), week 22 (n = 407), 2 mo postnatal (n = 432), or 2.5 yr 
postnatal (n = 452) stages of  human development, where n = num- 
ber of myogenic colonies scored from each developmental stage. 
The presence of myogenic colonies and the percent of those col- 
onies expressing slow MyHC was determined by double-immuno- 
fluorescence staining with the antibody F1.188, that recognizes all 
prenatal MyHCs and A4.951, that recognizes slow MyHC. A col- 
ony was scored positive for a given antibody if five or more myo- 
tubes were recognized by A4.951 in that colony. Error bars were 
calculated as the standard error of the proportion. 
periods  of both  primary  and  secondary fiber  formation, 
when the proportions of slow fibers differ markedly (Table 
I).  Primary dissociates were grown at clonal density and 
each clone allowed to differentiate to form multinucleated 
myotubes.  The expression of MyHCs was  defined in  the 
resulting myotubes at several time points after the cultures 
were placed in FM to differentiate. 
We identified those clones which were myogenic by double 
immunofluorescence. Antibody F1.188  recognizes an epi- 
tope present in all fiber types in prenatal muscle, and thus, 
is  a  control for the  presence of MyHC-expressing cells. 
Identification of myogenic clones was necessary because the 
proportion of total clones in culture that are myogenic differs 
in cultures from different stages of development (see below). 
Fig. 3 shows that cells isolated from tissues of early and 
late developmental stages (weeks 7,  16, and 22 of gestation 
and 2.5 years after birth) contain cells which are capable of 
expressing slow MyHC in culture. In fact, by 4 wk in FM, 
virtually all  individually scored myogenic colonies  (n  = 
2119,  total from six developmental stages)  expressed the 
slow MyHC recognized by A4.951 (Fig. 3). These results in- 
dicate that the progeny of all clonable human myoblasts have 
the potential to express slow MyHC in culture. Thus, even 
at week 22, a time in development when the majority of  myo- 
blasts would have contributed to the 97 % of fibers that did 
not synthesize detectable slow MyHC, these myoblasts read- 
ily give rise to fibers that express slow MyHC in culture. 
Expression of Slow MyHC Does Not Require Continu- 
ous Presence of  Serum Factors. The results presented above 
suggested that slow MyHC expression in muscle cells in vivo 
is mediated by muscle-extrinsic factors. Humoral factors are 
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pressed in cultured myogenic 
colonies regardless of devel- 
opmental stage of the source. 
Muscle tissues at embryonic 
week 7 (a, b), 16 (c, d) and 22 
(e, f), or postnatal year 2.5 
(g,  h)  were  dissociated  and 
mononucleated cells grown in 
GM for 10 d, then allowed to 
differentiate in FM for 4 wk. 
The simultaneous presence of 
F1.188- (a, c, e, g) and A4.95 l- 
reactive (b, d, f, h) myosins 
were  assayed by  double-im- 
munofluorcscence 4 wk after 
switching to FM. All colonies 
derived  from  each  develop- 
mental  stage eventually  ex- 
pressed  moderate  to  high 
levels  of slow MyHC.  Bar, 
30/~m. 
known to affect the phenotype of muscle fibers after birth in 
vivo and in culture (Gustafson et al.,  1985; Izumo et al., 
1986; Narusawa et al., 1987; Weydert et al., 1987). Innerva- 
tion is also known to influence MyHC expression in mature 
fibers in vivo (for review see Pette and Staron,  1990) and 
could, in theory, alter myoblast phenotypes in vivo. How- 
ever, because the expression of slow MyHC that we observed 
occurred in tissue culture, it clearly did not require the con- 
tinuous presence of nerves. To determine the extent to which 
the expression of slow MyHC required soluble factors in the 
culture medium that might have been contributed by serum, 
mass cultures of ceils derived either from muscle at week 9 
of gestation or from adult muscle were induced to differenti- 
ate in a defined medium containing DME with insulin (10  -6 
M) and dexamethasone (10  -6 M). Although these cells were 
exposed for FBS and chick embryo extract during growth 
as nondifferentiating myoblasts, during the time course of the 
experiment examining differentiation potential (~2 wk), the 
cells were not exposed to neural signals,  and were main- 
tained under well-defined serum-free conditions, No differ- 
ence was observed in the ability of both early embryonic and 
adult-derived cultures to express slow MyHC under these 
conditions.  These results suggest that factors from serum 
were not responsible for the induction of slow MyHC during 
differentiation in tissue culture. 
Although Myoblasts  from All Stages Express 
Slow MyHC, They Differ in Their Expression of 
Developmental Stage-specific MyHCs 
Although cells from different stages did not differ in their ex- 
pression of slow MyHC, they differed with respect to at least 
three other parameters. First, myotubes formed from myo- 
genic cells of muscle at week 7 of gestation were generally 
short and small in diameter (Fig. 4  a), whereas myotubes 
formed from muscle cells at later stages of gestation were 
much longer and greater in diameter (see Fig. 4 g), in agree- 
ment with previous studies  (Bonner and Hauschka,  1974; 
Hauschka, 1974). Second, the proportion of myogenic cells, 
as determined by reactivity of myotube colonies with anti- 
body FI.188, differed at different stages of development. Stri- 
ations in MyHC+  cells of week 7  muscle cultures (Fig. 4 
a) indicate that these small,  labeled cells are indeed myo- 
tubes.  The percentage of myogenic colonies after 4  wk of 
differentiation in culture increased from 24%  (n  =  442) at 
week 7  of gestation; to  88.7%  (n  =  122) at week 22;  to 
90.3% (n =  557) at 2.5 yr postnatal. Third, myogenic cells 
from different stages differed in the potential to express a de- 
velopmentally regulated neonatal fast MyHC isoform, as de- 
scribed in detail below. 
The potential to express slow MyHC did not distinguish 
The Journal of Cell Biology, Volume 121,  1993  800 Figure 5. F1.652 recognizes embryonic MyHC and N3.36 recognizes neonatal MyHCs in human muscle tissue and cultures. Extracts of 
human thigh muscle at week 22 (wk 22) of gestation, adult human muscle cultures differentiated in culture for 1 wk (1 wk) 2 wk (2 wk) 
or 3 wk (3 wk) and adult human diaphragm tissue (At/)) were electrophoresed through high-resolution glycerol/SDS 5.5 % polyacrylamide 
gels. One set of samples was silver stained (left) and two identical sets were transferred to PVDF membrane. Individual panels of  membrane 
were reacted with antibodies as described in Materials and Methods. The positions of types I, Ha, and IIb MyHC are indicated, as defined 
by Klitgaard et al. (1990). In MyHC extracts of prenatal muscle and of muscle cultures, antibodies F1.652 and N3.36 both recognize a 
band of distinct mobility (E/N), which has been shown  to contain embryonic and neonatal MyHC isoforms2; we have determined that, 
in these extracts, N3.36 recognizes a MyHC that is distinct from embryonic MyHC because, unlike F1.652, it does not recognize MyHC 
as early as week 14 of gestation. 
myoblasts of different stages, however,  it remained possible 
that other characteristics which distinguish developing mus- 
cle fibers are determined at the level of the myoblast, as sug- 
gested by studies in other species (Bonner and Hauschka, 
1974;  Cossu et al.,  1985;  Mouly et al.,  1987; Smith and 
Miller, 1992; Song et al., 1992).  For example, two types of 
muscle fibers, designated ~primary" and %econdary  ~ fibers, 
differ in time of appearance, size and morphology. Both are 
produced by the fusion of mononucleated myoblasts into 
differentiated multinucleated fibers. Primary fibers form in 
clusters, interconnected by gap junctions, and begin to sepa- 
rate by the formation of basal laminae. Secondary fibers are 
thought to arise from replicating myoblasts adjacent to pri- 
mary fibers which eventually become distinct by forming 
their own basal laminae (Kelly and Zacks, 1969; Ontell and 
Dunn, 1978).  Until late gestation in humans, primary fibers 
can be readily distinguished from secondary fibers by their 
relatively large size (Wohlfart, 1937; Fidzianska, 1980a) and 
by their expression of slow MyHC (Rubinstein and Kelly, 
1981;  Phillips  and  Bennett,  1984;  Crow  and  Stockdale, 
1986;  Condon et al.,  1990a). 
These differences between primary and secondary fibers 
suggested that the human myoblasts that give rise to them 
might differ with respect to the potential to express proteins 
which are specific to primary or secondary fibers. Therefore, 
to characterize the pattern of developmental stage-specific 
MyHC expression we examined stages when primary and 
secondary fibers are being formed, mAbs were used that 
could distinguish MyHC isoforms early in muscle develop- 
ment, even in the presence of other MyHC isoforms. These 
reagents were raised against human MyHCs partially pu- 
rified from either fetal, neonatal or adult human muscle, 
as described previously (Silberstein et al., 1986; Webster et 
al., 1988b).  The reactivity of these antibodies with isoforms 
of MyHC was  extensively characterized by Western blot 
analysis (Cho et al., submitted): first, each of the antibodies 
was tested in Western blots of whole-cell lysates of cultured 
human myotubes and rat muscle tissue and found to react ex- 
clusively with a protein of relative mol wt of ~o 200 kD, the 
size of MyHC. Second, each antibody showed a distinct pat- 
tern of  reactivity in Western blots of  purified human MyHes 
that were separated on high-resolution glycerol/SDS-poly- 
acrylamide gels (Klitgaard et al., 1990; La Framboise et al., 
1990). On these gels, four bands are resolved, type I (slow), 
embryonic/neonatal (E/N), type IIa (fas0 and type Ub (fast). 
Third, the MyHC isoform specificity of each antibody was 
determined by immunoblotting of antibodies with proteins 
encoded by MyHC cDNAs or with cell- or tissue-lysates 
which contain one predominant MyHC isoform.  2 
FI.652 Recognizes  Embryonic  MyHC in  Primary and 
Secondary  Fibers.  mAb F1.652  is  specific for embryonic 
MyHC by several criteria. First, F1.652 reacts exclusively 
with ,x,220-kD protein in Western blots of whole-ceU lysates 
of human myotubes differentiated in tissue culture (Silber- 
stein et al., 1986) which shows that it is specific for the heavy 
chain of myosin. Second, F1.652 reacts only with partially 
purified extracts from embryonic stages of human muscle 
tissue in Western blots. For these blots, extracts were elec- 
trophoresed  through  high-resolution  SDS-polyacrylamide 
gels under conditions which resolve types I, Ha,  and fib 
MyHCs from adult muscle (Klitgaard et al.,  1990).  In such 
blots, F1.652 reacts with a distinct MyHC both in extracts of 
skeletal muscle at weeks 142 and 22 of gestation, and in ex- 
tracts of cultured human myotubes, but not with any MyHCs 
(I,  Ha,  or llb)  in extracts of adult muscle  (Fig.  5).  The 
F1.652+  MyHC in prenatal  muscle migrates  faster than 
adult type Ha but slower than type I MyHC under our condi- 
tions. Third, F1.652 reacts with the protein expressed from 
the human embryonic MyHC cDNA,  pSMHCE  (Karsch- 
Mizrachi et al., 1989). We previously designated the MyHC 
recognized by antibody FI.652 as fetal (Silberstein and Blau, 
1986), because human muscle at 15 wk of  gestation was used 
as the source of the MyHC antigen. However,  because the 
gene encoding the epitope recognized by this antibody is 
most homologous to the embryonic MyHC gene in the rat 
(Karsch-Mizrachi et al., 1989; Strehler et al., 1986), and is 
expressed not only at fetal but also at embryonic stages of  hu- 
man development, we now refer to this isoform as embryonic 
MyHC. 
Embryonic MyHC is the first detectable MyHC in newly- 
formed primary and secondary fibers (Fig. 6 a). Its expres- 
sion persists in most fibers throughout embryonic develop- 
ment, ceasing shortly after birth (Webster et al.,  1988b). 
Embryonic MyHC is clearly detectable in primary fibers as 
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is expressed  in all primary and 
secondary fibers during gesta- 
tion.  Transverse sections of 
human limb muscle at weeks  8 
(a,f),  10 (b, g), 17 (c, h), 21 
(d, i), and 27 (e, j) of gesta- 
tion were reacted with anti- 
body F1.652 (a-e) followed  by 
an FITC-conjugated  goat anti- 
mouse IgG second antibody. 
Phase  contrast  micrographs 
(f-j) are the same fields  shown 
in immunofluorescence  (a-e) 
and in Fig. 2. Arrows indicate 
the same primary fibers in (d) 
and  (t)  which no longer ex- 
press embryonic MyHC  by 
week 21. Bar, 100/~m. 
early as week 6 (data not shown) and week 8 of gestation 
(Fig. 6 a) and thereafter in all muscle fibers (both primary 
and secondary), a pattern that continues throughout the first 
half  of human gestation (Fig. 6, a-c). Embryonic MyHC ex- 
pression declines progressively first in large primary fibers 
in midgestation (Fig. 6 d) and the overall staining intensity 
with F1.652 begins to decline in late gestation (Webster et 
al., 1988b). Embryonic MyHC is no longer detectable in any 
muscle fibers by 2 wk after birth (Webster et al.,  1988b). 
These  data corroborate  the results obtained from a  time 
course of tissue samples analyzed by Western blotting. The 
FI.652 antibody therefore serves as a marker of early MyHC 
expression in both primary and secondary fibers. 
N3,36 Recognizes Neonatal MyHC Present in Second- 
ary but Not Primary F/hers. mAb N3.36 recognizes neona- 
tal MyHC in developing human muscle (Fig.  5).  First,  it 
reacts exclusively with a 220-kD protein in whole-cell ly- 
sates of cultured human myotubes (Silberstein et al., 1986). 
Second,  analysis of N3.36  reactivity in Western blots  of 
high-resolution gels showed that it is specific for a neonatal- 
specific MyHC which is of mobility intermediate between 
adult type I and IIa MyHCs. Western blots of tissue samples 
on denaturing gels show reactivity of N3.36 with neonatal 
and adult stages, but not fetal, whereas F1.652 is specific for 
fetal stages (Silberstein et al., 1986). However, N3.36 recog- 
nizes a MyHC that is distinct from embryonic MyHC be- 
cause, unlike F1.652,  it does not recognize MyHC as early 
as  week  14  of gestation.: Third,  the reactivity of N3.36 
with polypeptides encoded by MyHC cDNAs revealed that 
the antibody recognizes an MyHC encoded by the neonatal 
(perinatal)  MyHC cDNM  (pSMHCP;  Feghali and Lein- 
wand, 1989; Karsch-Mizrachi et al., 1990).  A probe to the 
5' half of neonatal MyHC cDNA detects mRNA by RNase 
protection in muscle at midgestation (week 21) but not in the 
adult.  This timecourse of mRNA expression parallels the 
timecourse observed for N3.36-reactive proteins, with the 
exception that in adult muscle, N3.36  reacts with a bend 
migrating at the type IIa position. These data suggest that 
N3.36 recognizes an epitope present on at least two MyHC 
isoforms: a neonatal MyHC in developing muscle which is 
first  expressed  in  midgestation  and  corresponds  to  the 
perinatal cDNA,  and an adult MyHC which is expressed 
only in adult muscle. It should be noted that, as shown in Fig. 
5, only the neonatal isoform is recognized by N3.36 in ex- 
tracts of cultured human muscle cells. For the purposes of 
the studies described here which use cultured cells, N3.36 
can  be  considered  as  neonatal-specific  and  F1.652 as 
embryonic-specific. 
N3.36 recognizes MyHCs only in secondary, fast fibers 
(Fig. 7, a-c). Secondary fibers form around week 9 of  human 
gestation and can be distinguished from primary fibers by 
their smaller size until week 30 of gestation (Wohlfart, 1937; 
Fig. 7, a-c); thereafter, primary and secondary fibers are es- 
sentially equivalent in size. In addition, reactivity of  primary 
fibers with a  mAb to  slow  MyHC, A4.951,  distinguishes 
them  from newly-formed secondary fibers  (Fig.  7,  d-f). 
These fibers are not recognized by antibody N3.36. Neonatal 
MyHC is not apparent by immunofluorescence analysis of 
cryostat sections at week 12 of gestation, but is prevalent by 
week 21 (Fig. 7). Thus, embryonic MyHC precedes neona- 
The Journal  of Cell Biology,  Volume 121, 1993  802 Figure 7. Neonatal MyHC is expressed only in secondary fibers. 
Transverse sections of human limb muscle at weeks 12 (a, d, g), 
21 (b, e, h), or 27 (c, f, i) of gestation were analyzed by double- 
immunofluorescence: reaction with both antibody N3.36 (a-c) to 
neonatal MyHC followed by a rhodamine-conjugated goat anti- 
mouse IgM second antibody and with antibody A4.951 (d-f) to 
slow MyHC followed  by an FITC-conjugated  goat anti-mouse IgG 
second antibody. Phase contrast micrographs of the same fields 
shown in a-c and d-fare shown in g-i. Arrows in b, e, and h indi- 
cate the same primary fibers, which express slow but not neonatal 
MyHC. Short ~s  in c,f, and i indicate a primary fiber, whereas 
the long ~s  indicate a secondary fiber. Both fibers express slow 
MyHC but not neonatal MyHC. Bar, 100 tim. 
tal MyHC in secondary fibers. By week 27 of  gestation, neo- 
natal MyHC is present in all fast fibers, but absent in fibers 
which contain slow MyHC (Fig. 7 c). In adult muscle, N3.36 
reacts very weakly with fibers that contain fast ATPase activ- 
ity (Silberstein et al.,  1986;  Webster et al.,  1988b).  These 
results are consistent with those obtained by Western blot- 
ting and suggest that a neonatal MyHC is expressed only in 
secondary, fast fibers of developing muscle.  Thus,  N3.36 
serves as a useful marker of MyHC specific to secondary, 
but not primary, fibers. 
In summary, antibodies F1.652 and N3.36 recognize em- 
bryonic and neonatal MyHCs that are developmentally regu- 
fated and differentially expressed in primary and secondary 
fibers. By contrast, F1.188 serves as a control to indicate the 
presence of sarcomeric MyHC in muscle cultures and tis- 
sues.  Thus,  F1.652  serves  as  a  marker  of early  fibers, 
whereas N3.36 is specific to later stages of fiber formation. 
Evidence for Heterogeneity: Myoblasts from Early and 
Late Embryos Express Different  Developmentally Regu- 
lated MyHCs.  We determined whether the myoblasts pres- 
ent when primary and secondary fibers are forming differ in 
their potential to express developmentally  regulated MyHCs. 
Myoblasts were isolated from muscle tissues at 7 wk (early 
primary fiber formation) and 9  wk (early secondary fiber 
formation) of gestation and compared with myoblasts from 
muscle at four later stages of development (16 and 22 wk of 
gestation, 2 mo and 2.5 yr after birth). The cells were plated 
at low density and the progeny of each cell were followed as 
distinct clones. Individual clones were allowed to differen- 
tiate to form multinucleated myotubes for up to 4 wk in FM. 
Between 150 and 450 individual colonies were analyzed for 
each of the six developmental stages. Colonies were identi- 
fied as myogenic by their synthesis of MyHC using antibody 
F1.188 and assessed for their expression of developmentally 
regulated embryonic or neonatal MyHC isoforms by double 
immunofluorescence with antibodies FI.652 or N3.36. 
A marked difference in MyHC expression was observed 
between myoblasts isolated from the two earliest stages of 
muscle development (Fig. 8).  All myogenic clones at week 
7 (total of 165 clones) expressed embryonic MyHC after 4 
wk of differentiation in culture, but none expressed the neo- 
natal isoform. By contrast, all myogenic clones from week 
9 (total of 393 clones) or later stages (total of 1,109 clones) 
expressed both the neonatal and embryonic MyHCs. These 
results were consistent for clones isolated from muscle tis- 
sues of three different individuals at week 7  and week 9, 
respectively (total of 938  clones).  Because the results for 
myoblasts from tissue at the four later stages were similar, 
only data for myoblasts from the latest, 2.5 yr.  postnatal 
muscle, are shown. They do not differ from those obtained 
from week 9 clones, except that the lag period before the on- 
set of neonatal MyHC expression is shortened. These results 
suggest that myoblasts differ in their intrinsic potential to in- 
duce expression of a developmentally-regulated gene. 
Week 7 and week 9 clones also differed in their ability to 
turn off gene expression. Week 7 myotubes did not induce 
neonatal MyHC expression, and continued to express em- 
bryonic MyHC, even after 4 wk in FM (Fig. 9, a and b). By 
contrast, a reciprocal relationship was observed in cells from 
week 9: those myotubes that initiated expression of neonatal 
MyHC ceased to express the embryonic isoform (Fig.  9, 
c-h). This difference  was apparent when the myotnbes within 
clones were analyzed. A  clone could be positive for both 
MyHCs, but some myotubes were N3.36+  whereas other 
myotubes were positive for F1.652; at late time points in cul- 
ture, these MyHCs were generally not co-expressed. That 
week 7 myotubes continue to express embryonic MyHC and 
do not induce neonatal MyHC is not due to their failure to 
thrive;  these myotubes persist for as many weeks as my- 
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Figure 8. Time  course of embryonic and neonatal MyHC expres- 
sion in cultured human muscle cell colonies. Colonies were derived 
from myoblasts  in muscle tissues at embryonic week 7 (n =  165), 
week 9 (n = 393), or 2.5 yr postnatal (n = 452) where n = number 
of colonies at each stage scored as myogenic, based on reactivity 
with antibody F1.188. Myoblasts were plated at clonal density in 
growth medium (GM). Colonies were grown to ~1,000 cells each, 
and then switched to a low-serum fusion medium (FM) to induce 
differentiation. The percent of myogenic colonies that expressed 
embryonic (FI.652) or neonatal (N3.36) MyHC was determined by 
double-immunofluorescence.  A colony was scored as positive for 
a given antibody if five or more myotubes  exhibited a signal above 
background. Error bars were calculated as the standard error of the 
proportion. The results at each time point (weeks 7 and 9 of gesta- 
tion) are representative  of  three muscle samples from three different 
individuals. 
otubes from older stages and are capable of inducing expres- 
sion of other MyHCs, for instance, slow MyHC. Thus, myo- 
blasts differ in their intrinsic potential not only to express but 
also to repress a developmentally regulated gene upon differ- 
entiation. 
The switch from embryonic to neonatal MyHC expression 
in week 9 cultures represents a developmental progression 
in MyHC isoform expression, as illustrated by the following 
three observations.  First, the overall intensity of staining 
with the F1.652 antibody at late time points was reduced rela- 
tive to that in colonies at early time points. Second, an analy- 
sis of the proportion of individual myotubes within a colony 
expressing embryonic or neonatal MyHC revealed a gradual 
replacement of the embryonic by the neonatal isoform. Ac- 
cordingly, most (90%) of myotubes within a myogenic col- 
ony from week 9  expressed only embryonic MyHC after 
1 wk in FM, a mixture of embryonic and neonatal MyHCs 
at 2-3  wk, and only neonatal MyHC by 4  wk (data not 
shown). However, a few myotubes in each colony could be 
seen that express embryonic MyHC even after 28 d in cul- 
ture. These were presumably the last to form, because they 
were generally smaller in size and located at the periphery 
of the colony. This heterogeneity among myotubes within a 
given clone explains why, in Fig.  8,  clones derived from 
week 9 or later stages appear to continue to express em- 
bryonic MyHC in  culture;  in  this  analysis, clones were 
scored as positive for a specific MyHC if they contained five 
or more myotubes that expressed detectable levels of that 
MyHC by immunofluorescence. By contrast,  in previous 
studies with adult-derived C2C12 mouse muscle clones, all 
myotubes  eventually  replaced  embryonic  with  neonatal 
MyHC (Silberstein et al., 1986). In these experiments, cyto- 
sine arabinoside was used to inhibit myoblast proliferation 
and de novo myotube formation at the periphery of colonies. 
The use of an inhibitor of DNA synthesis was precluded 
here, because it is toxic to embryonic muscle cells. Thus, 
week 9, but not week 7, cultures sequentially express two de- 
velopmentally distinct MyHCs, eventually replacing em- 
bryonic with neonatal MyHCs. 
We conclude from these studies that human muscle colo- 
nies from week 7 differ from their later counterparts in at 
least two aspects of gene regulation: early cells express em- 
bryonic MyHC continuously and do not switch on expres- 
sion of neonatal MyHC. 
Extrinsic Factors:  No Effect on Intrinsic Potential of 
Myoblasts in Culture. To rule out the possibility that the de- 
velopmental differences in isoform expression arose because 
the myoblasts from very early embryos were more sensitive 
to culture at the low density required for clonal analysis, we 
plated cells at high density. In these experiments, cells plated 
at 1,000 cells/era  ~, and grown to confluence were compared 
with those plated  at a  clonal density of 1 cell/cmL For 
clones of both week 7 and week 9 samples, differentiation 
of myotubes and detection of MyHC by antibody F1.188 was 
apparent three to 4 d earlier in the high density cultures than 
in low density cultures. In addition, the progression from 
embryonic to neonatal MyHC was accelerated twofold in the 
week 9  samples. By contrast, in spite of their precocious 
differentiation, week 7 samples strongly expressed embry- 
onic MyHC for the 20 d duration of the cultures in FM and 
neonatal MyHC was not induced. Thus, the inability of  week 
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gression  from embryonic  to 
neonatal  MyHC  expression 
occurs only  in late-stage  hu- 
man  muscle  cells.  Colonies 
were derived  from tissues  of 
embryonic week 7 (a, b), and 
week  9  (c-h)  as  described 
in the legend to Fig. 4. They 
were analyzed simultaneously 
for expression  of embryonic 
MyHC  (F1.652-reactive:  a, 
c,  e, g) and neonatal  MyHC 
(N3.36-reactive: b, d, f, h) by 
double-immunofluorescence  at 
10 (c, d),  14 (e, f), or 28 (a, 
b, g, h) days after switching to 
FM. Left and right panels are 
the same fields in each case. 
Bar, 30 ~m. The myotubes in 
g  have lost  F1.652 reactivity 
and  are typical  of most ma- 
ture  myotubes  at  the  center 
of each week 9 myogenic col- 
ony. By contrast, the edges of 
each  colony contained  many 
(at least five) less mature myo- 
tubes which still reacted with 
F1.652. As a result, the data in 
Fig. 5 do not show the decline 
in  expression  of  embryonic 
MyHC with time shown here. 
Striations are not visible in the 
myotubes  stained  with  anti- 
bodies to embryonic MyHC, 
because this isoform is over- 
whelmingly  predominant  in 
these  cells  and  the  resulting 
fluorescent  staining  of  this 
MyHC is  very intense.  (See 
Fig. 4 for visualization of stri- 
ations in similar cultures, us- 
ing antibodies to slow MyHC.) 
7 cultures to express neonatal MyHC was not altered by ac- 
celerated differentiation at higher plating density (Table II). 
To determine whether factors in the culture medium were 
responsible for inducing the changes in isoform expression 
in  week 9  cultures,  cells were differentiated  in  a  defined 
medium.  For  this  purpose,  tissues  were  dissociated  and 
plated at high density, grown to confluence in GM, and then 
differentiated either as usual in FM containing chick embryo 
extract and horse serum or in a  serum-free medium con- 
sisting of DME with insulin  (10  -~ M)  and dexamethasone 
(10  -~  M)  for  ,02  wk.  Differentiation  and  expression  of 
MyHC occurred several days earlier in defined medium than 
in complete medium, indicating that undefined humoral fac- 
tors in the media are not the basis for neonatal MyHC induc- 
tion in week 9 samples (Table II). Week 7 cells could not be 
analyzed  because  they  detached  from  the  culture  dishes 
within one week of culture in serum-free medium. 
The possibility remained that  the  inability  of myogenic 
cells in week 7 cultures to express neonatal MyHC resulted 
from an inhibitory factor in those cultures provided, for ex- 
ample, by the nonmyogenic cells. The proportion of clones 
that were myogenic in week 7 cultures was ,~30 % compared 
to 50%  in week 9  cultures,  determined by morphological 
evidence of myotube formation and detection of MyHC with 
antibody F1.188.  We designed experiments to test whether 
the nonmyogenic clones contributed factors that suppressed 
the expression of neonatal MyHC in myogenic clones. For 
this purpose, cells from week 7 were mixed with cells from 
week 9  either at a ratio of 10:1 or 5:1  and plated at clonal 
density. Colonies were grown in GM, switched to FM, and 
scored for expression of neonatal MyHC after 21 and 28 d 
in FM.  The proportion of myogenic clones that expressed 
neonatal MyHC at these two ratios was 41%  (43/106) and 
48 % (43/90), respectively. Because in these mixed cultures, 
week 9 myogenic clones should comprise 14 and 30% of the 
total clones, respectively, it appears that the lack of expres- 
sion of neonatal MyHC is not due to an inhibition by the 
presence of week 7  nonmyogenic cells in the cultures.  To 
show definitively that a positive factor contributed by week 9 
cultures induced week 7 cultures to express neonatal MyHC 
Cho et al. Extrinsic Control of Muscle Fiber Type  805 Table IL Extrinsic Factors and Cell Division Do Not Induce Expression of Neonatal MyHC in Embryonic Week 7 
Muscle Cultures 
Week 7  Week 9 
Extrinsic factors  Sample  % N3.36 positive  Sample  % N3.36  positive 
Clonal cultures,  sample  1*:  165  0%  sample  1:393 
differentiated in FM*  sample 2:  87  sample 2:189 
(1  cell/cm  2)  sample 3:64  sample 3:40 
total:  316 colonies  total:  622 colonies 
100% 
High density cultures 
differentiated in FM*  0% 
(103  cells/crn  2) 
High density cultures, 
in defined mediumll 
(10  ~ ceUs/cm2  )  ND§ 
Cell divisions:  Five serially-passaged  0%  Three serially-passaged  100% 
serial subcloning  subclones  subclones 
(25 doublings each)  (25  doublings each) 
100% 
100% 
* Fusion medium (DME, 5% horse serum,  104 M insulin,  10  -~ M dexamethasone). 
Data for Fig. 4 were obtained from sample 1 of each stage; as shown here, similar results were obtained from clonal cultures derived from two additional sam- 
pies from week 7 and week 9 each (samples 2 and 3 from each stage). 
§ Not determined. 
II Same as in * but without  horse serum. 
will require additional experimentation in which cells are la- 
beled so that the week 7 and week 9 myoblasts can be distin- 
guished and the plating efficiency of the two cell types deter- 
mined to be equal. 
Thus, the pattern of MyHCs expressed by myoblasts that 
differentiate in culture mimics that of the stage of develop- 
ment in the intact organism from which they were derived, 
irrespective  of extrinsic cues provided by media compo- 
nents, cell density or culture composition. 
Expression Patterns of  MyHC Are Stably Heritable. Two 
possible explanations for the differences between myoblasts 
from week 7 and week 9 muscle are (a) two independent 
myoblast populations arise at different times, or (b) the early 
population gives rise to the later one. If week 7 myoblasts 
gave rise to week 9 myoblasts, this could be in response to 
either an environmental cue or to a cell-intrinsic division- 
dependent maturation. To test the possibility that commit- 
ment to a particular pattern of MyHC expression was under 
control of an intrinsic mechanism, myoblasts from week 7 
and from week 9 muscle were serially subeloned in culture 
until they had undergone a minimum of 25 population dou- 
blings in GM. The cells were then induced to differentiate 
by exposure to FM. As the cell cycle for human embryonic 
myoblasts is "024 h, this period is nearly equivalent to 4 wk, 
twice the difference in gestational age at the time of myoblast 
isolation. The five serially passaged clones analyzed from 
week 7, like the parental clones from which they were de- 
rived, expressed embryonic, but no neonatal MyHC (Table 
II). The three serially passaged clones from week 9 muscle, 
on the other hand, all expressed neonatal MyHC. From these 
results it seems likely that the expression of neonatal MyHC 
is not under the control of a division-dependent mechanism, 
or intrinsic "clock: 
Discussion 
The Proportion of  Slow MyHC-expressing b~bers 
Changes Markedly During Embryonic Development 
During development, tissues arise that are composed of  mul- 
tiple cell types distributed in complex patterns. Here we have 
addressed one possible mechanism for achieving the pattern 
of diverse muscle cells, or fibers, characteristic of human 
skeletal muscle of the limb. Specifically,  we have tested the 
hypothesis that the heterogeneity of  muscle fibers specialized 
for fast or slow contractions is intrinsically determined at the 
level of the myoblasts, as suggested by Miller and Stockdale 
(1986a,b). 
During human gestation, the percentage of total fibers in 
muscle tissue that are slow fibers changes markedly from 
,075 to 3 to 50%. This is due to the progression of events 
underlying  muscle  development.  The  early,  or  primary 
population of fibers is homogenous with respect to both on- 
set and continued expression of slow MyHC. At a time when 
the  vast  majority primary  fibers  express  slow  MyHC,  a 
population of secondary fibers arises,  which does not ex- 
press slow MyHC. Indeed, secondary fibers fail to express 
slow MyHC for the entire second trimester of gestation (for 
>12 wk). At the beginning of the third trimester, slow MyHC 
begins to be detected in a small subset of secondary fibers. 
From this time onward, the increase in the number of slow 
fibers is extremely rapid, reaching adult proportions in only 
three weeks. Because this increase cannot be accounted for 
by de novo formation of fibers, it appears that a fiber-type 
transition  is  occurring  in  a  preexisting  set  of secondary 
fibers. These results in human muscle are in agreement with 
those in rat (Narusawa et al.,  1987) which show that slow 
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first phase occurring early in primary fiber development and 
the second phase occurring late in secondary fiber devel- 
opment. 
The Intrinsic Potential of  Myoblasts to Express Slow 
MyHC Is Suppressed In Vivo 
The failure of secondary fibers to express slow MyHC for 
months after their formation suggested to us that these fibers 
might differ inherently from their primary counterparts. Be- 
cause fast and slow myoblast lineages had been reported by 
others (Stockdale et al., 1988), we tested the possibility that 
the myoblasts that form primary and secondary fibers differ 
intrinsically in  their  commitment to  a  program  of slow 
MyHC expression. 
The results were striking: virtually all myoblasts, irrespec- 
tive of the stage of development from which they were de- 
rived, gave rise to clones that expressed slow MyHC upon 
differentiation in culture. This was true even for myoblasts 
from muscle at midgestation, a time when only 3 % of fibers 
expressed  slow MyHC. These results suggest that culture 
conditions are permissive for an inherent ability of  myoblasts 
from all developmental stages to express slow MyHC. By 
contrast, in vivo, this expression must be suppressed.  Hu- 
moral factors found in media are not likely to be responsible 
for the expression of slow MyHC in the cultures. Elimination 
of serum from the medium did not affect the phenotype of 
myoblasts cultured from either embryonic or adult tissues. 
Instead, the lack of expression of slow MyHC in vivo is 
likely to reflect a specific suppression in secondary fibers. 
Reconciliation of  Apparent Species Differences 
in Slow MyHC Expression 
Our results appear to differ markedly from those previously 
reported by others, however, these differences can be readily 
reconciled and explained by a single unifying principle, as 
described below.  First, human myoblasts differ from avian 
myoblasts in tissue culture in that an early population of hu- 
man myoblasts is homogeneous with respect to the potential 
to express slow MyHC, whereas chicken myoblasts are het- 
erogeneous (Miller and Stockdale,  1986a,b).  This distinc- 
tion is also reflected in the primary fibers of intact muscles 
of the organism. Avian muscles contain both slow twitch 
(type I) and slow tonic (type III) fibers. Slow tonic fibers re- 
tain multiple innervation and exhibit graded contractions, in 
contrast to the monoinnervation and all-or-nothing contrac- 
tile response of both fast and slow twitch fibers in mammals 
(for review see Schmalbruch, 1985). Indeed, in zebra finch 
muscles, an antibody that recognizes the SM2 slow myosin 
of chicken reacts only with fibers that have multiple termi- 
nals (Bleisch et al., 1989).  Thus, it may be that the expres- 
sion of the slow isoform SM2 by early but not late chicken 
myoblasts represents additional fiber-type heterogeneity typ- 
ical of avian but not mammalian muscle. 
Second, in spite of the differences among species in the 
types of slow fibers they contain, similar rules appear to gov- 
ern fast and slow fiber type development. At first, it appears 
that the existence of multiple slow MyHC isoforms in the 
chicken precludes a direct comparison of clonal analyses in 
chicken and human. Early results from chicken muscle cells 
(Miller and Stockdale, 1986a,b) showed that the slow myo- 
sin isoform SM2 was expressed by early myoblasts but not 
late myoblasts and  that a  similar expression pattern  was 
found in muscle fibers from corresponding stages in viv,~ As 
a result, it was proposed that distinct lineages of myoblasts 
gave rise to fast and slow fiber types. However, more recent 
studies of chicken myoblasts (Miller and Stockdale,  1989) 
that used a different mAb to analyze expression of another 
slow myosin isoform of chicken muscle, SM1, are in good 
agreement with our results. These studies show that SM1 is 
expressed by both early and late myoblasts in culture and 
in the corresponding fibers in vivo and therefore that slow 
MyHC per se does not distinguish early and late myoblast 
populations. Experiments in mouse muscle that demonstrate 
expression of slow MyHC in early- but not late-type myo- 
blasts (Vivarelli  et al., 1988) could also be explained by the 
presence of multiple slow isoforms in this species.  Indeed, 
results in our laboratory suggest that this is the case (Hughes 
et al.,  1993). A comparison of A4.951 with two other anti- 
bodies specific to slow MyHC (A4.840 and N2.261)  in ro- 
dent and in human muscle revealed that although A4.951 
is expressed at all stages of development, two other slow 
MyHCs are sequentially expressed in the same fibers at later 
stages of development. Taken together, these results indicate 
that myoblasts may be heterogeneous with respect to expres- 
sion of developmentally-regulated MyHC isoforms, but that 
these differences do not necessarily give rise to functional 
distinctions specific to fast and slow fiber types. 
Neuronal Factors May Be Permissive  for 
Fiber-type Determination 
Our studies suggest that slow MyHC expression is actively 
repressed in vivo.  This interpretation is also supported by 
data obtained from chicken muscle. Clonal analysis of early 
chick myoblasts in culture showed that, of the colonies that 
expressed slow MyHCs, none expressed the SM1  isoforrn 
without also expressing SM2 (Miller and Stockdale, 1989). 
In contrast, previous studies in vivo detected the SM1 iso- 
form in the absence of SM2 in primary fibers (Stockdale et 
al., 1988).  These results are consistent with our interpreta- 
tion that a specific suppression of slow myosin is occurring 
in vivo, in this case SM2, a suppression similar to that which 
we observed in secondary fibers in human muscle. 
Innervation has long been known to play a role in fiber- 
type determination, but whether this role is permissive or in- 
structive has not always been clear. There is strong evidence 
from experiments in rodent and avian muscle that early pri- 
mary fiber type determination is not neuronally controlled 
(Phillips  and Bennett,  1984;  Crow and Stockdale,  1986; 
Phillips et al., 1986; Sohal and Sickles, 1986; Narusawa et 
al., 1987; Weydert et al., 1987; Condon et al., 1990b). How- 
ever, irmervation is thought to be responsible for regulating 
slow MyHC expression in secondary fibers (Crow and Stock- 
dale, 1986).  Indeed, the appearance of slow MyHC in sec- 
ondary fibers of most muscles of the rat hindlimb has been 
recently shown to be dependent on irmervation (Condon et 
al.,  1990b). 
This apparent nerve-dependence of slow MyHC expres- 
sion in vivo might seem to conflict with our findings that ~;:~- 
pression of slow  MyHC is intrinsic to myoblasts from all 
stages of  development. However, nerves could play a permis- 
sive rather than an instructive role in the regulation of slow 
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relieve fibers from factors in vivo which partially  suppress 
the program of MyHC expression  intrinsic  to the myoblast. 
The following observation lends  support to our hypothesis 
that neural  signals modulate the expression of slow MyHC 
but that  positional  information  from the environment  dic- 
tates the specific response of a myofiber to those signals. In- 
vestigation  of the role of nerves in the regulation  of slow 
MyHC in neonatal and embryonic rats showed that the re- 
sponse to denervation  varied with the position of a  fiber 
within the leg (Narusawa et al., 1987; Condon et al., 1990b). 
In general,  deep regions  of muscle lost expression  of slow 
MyHC whereas other regions retained or increased  slow 
MyHC expression.  Our finding  that  100%  of the human 
myoblasts tested as clones in culture had the potential to ex- 
press slow MyHC, taken together with the denervation  stud- 
ies,  suggest that  myoblast-extrinsic  factors which are non- 
neuronal  yet region-specific  play a role in determining  the 
pattern of fiber type in the developing  muscle. 
At later stages of development (mid- to late-gestation),  the 
fast/slow phenotype of preexisting  multinucleated  fibers is 
likely to dominate over the developmental  potential  of the 
myoblasts which fuse into them (Hughes and Blau,  1992). 
Thus, the heterokaryon environment of the fibers is probably 
the most influential extrinsic influence at this stage. However, 
fusion of myoblasts into preexisting fibers cannot explain the 
phenotype of  the earliest-forming fibers. The earliest-forming 
secondary fibers are fast, yet begin to be generated at a stage 
(week 10 of gestation)  when all myoblasts have the intrinsic 
potential  to express slow MyHC. Thus,  neither  fusion into 
preexisting fibers nor intrinsic potential alone can explain the 
control of expression of MyHCs in the early stages of fiber 
development. Instead, environmental  cues could be provided 
by  neighboring  slow  primary  fibers,  nonmyogenic  cells, 
nerves or hormones. 
Early and Late Myoblasts Express Different MyHCs 
Although  we found that myoblasts at all stages of develop- 
ment tested could express slow MyHC, the same myoblasts 
differed in their ability to express a protein specific to sec- 
ondary fibers, neonatal  MyHC. Each myogenic clone from 
week 9 muscle,  a stage when secondary fiber formation  is 
just beginning,  was capable of sequentially  expressing  first 
the embryonic MyHC and then the neonatal  MyHC.  An 
analysis of the myotubes within clones revealed that this se- 
quence reflects a progressive replacement of the early by the 
late isoform.  In contrast, each myogenic clone of the total 
of 316 clones analyzed from week 7 muscle tissue of three 
different individuals (Table I), at a stage when primary fibers 
are forming,  was capable of embryonic MyHC expression 
but not neonatal MyHC, a pattern which persisted for 4 wk 
of cultivation  in differentiation  medium.  Thus,  the popula- 
tions of cells at these two stages of  development clearly differ 
intrinsically. 
Previous studies by others suggested that myoblasts might 
be heterogeneous at different stages of development. Hanschka 
and co-workers (Hauschka,  1974) defined developmentally 
distinct  populations  of chicken  and human myoblasts  that 
differed  in  their  morphology  and  medium  requirements 
(Bonnet and Hauschka, 1974; White et al.,  1975). Muscle 
colonies from early-stage  embryos differentiated  to  form 
small myotubes and required conditioned  medium, whereas 
colonies from later stage embryos formed large myotubes 
containing  hundreds of nuclei in the absence of conditioned 
medium. Cossu et al. (1985) showed differences in response 
to factors added to media:  Human myoblasts  from gesta- 
tional weeks 6-8 were prevented from differentiating by ex- 
posure to the phorbol ester 12-O-tetradecanoylphorbol-13- 
acetate (TPA), whereas myoblasts from week 10 and later 
stages gradually acquired resistance to TPA during develop- 
ment.  Here we show that myoblasts from two different de- 
velopmental stages differ biochemically and that these stages 
correlate with periods when primary and secondary fibers 
are forming. Our results demonstrate that the myoblasts that 
give rise to primary  and  secondary fibers  differ  in their 
potential to express developmentally  regulated genes encod- 
ing distinct  MyHCs. This  is in agreement  with results  ob- 
tained with chick, quail (Mouly et al., 1987), mouse (Smith 
and  Miller,  1992)  and  rat  (Song  et al.,  1991) myoblasts 
which indicate that early and late myoblasts differ in their ex- 
pression  of  several  muscle-specific  proteins  once  they 
differentiate.  By contrast, as shown here,  all myoblasts ap- 
pear to be able to express a"fiber type'-specific, slow MyHC 
after differentiation. 
Control of Switch in Potential to Express 
Neonatal MyHC 
We designed  experiments  to examine the prerequisites for 
the isoform switch observed in week 9 cultures. To determine 
whether extrinsic factors in the differentiation medium con- 
taining chick embryo extract and serum were responsible for 
the shift in MyHC expression,  we analyzed  the clones af- 
ter differentiation  in a defined medium.  These experiments 
showed that week 9 myogenic clones were able to express 
neonatal  MyHC even when the only humoral factors pro- 
vided were insulin and dexamethasone. To determine whether 
cell density was critical to the expression of neonatal MyHC, 
cultures were grown at high density. It seemed possible that 
week 7 cultures  did not undergo the developmentally  regu- 
lated  isoform transition  simply  because the  clones  were 
smaller and sparser than those derived from week 9 tissues. 
When plated as mass cultures and grown to confluence, week 
7  cultures  exhibited  accelerated differentiation  relative  to 
clonal cultures,  However, in spite of the precocious appear- 
ance of MyHC, the embryonic isoform persisted and was not 
replaced by the neonatal isoform after 20 d in differentiation 
medium.  Thus,  the expression  of the neonatal  isoform was 
not influenced by undefined serum components or cell density. 
Paracrine factors could be responsible for preventing  or 
promoting  maturation.  To explore this possibility,  we ana- 
lyzed cocultures of week 7 and week 9 clones. We reasoned 
that the lack of maturation and expression of neonatal MyHC 
by the early stage myogenic clones could be due to the secre- 
tion and accumulation  of inhibitory factors in the medium, 
as the proportion of noumyogenic clones in week 7 cultures 
was higher (50%) than in week 9 clonal cultures (30%). Ac- 
cordingly, we examined whether week 9 myoblasts could be 
prevented  from maturing  by the presence of noumyogenic 
cells, presumably fibroblasts.  However, when week 9 myo- 
genic clones were plated under conditions  where they were 
greatly  outnumbered by week 7 nonmyogenic  clones, they 
still  underwent  their  program  of embryonic to  neonatal 
MyHC isoform transition.  These experiments  suggest that 
inhibitory  factors are not responsible for the lack of matura- 
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maturation-promoting  factor is required.  To address these 
possibilities definitively, independent methods must be de- 
veloped for labeling and distinguishing individual clones in 
week 7 and week 9 cocultures. 
Generation of Two Myoblast ~es 
The  complete  change  in  the  ability  to  express  neonatal 
MyHC that occurs in the clonable myogenic population be- 
tween week 7 and week 9 of human gestation is striking. This 
finding  suggests  that  a  relatively  synchronous  change  oc- 
curred in the entire pool of undifferentiated muscle cells dur- 
ing this two week period. Such a change might either be sig- 
naled by an extrinsic  environmental  cue or be part  of an 
intrinsic  program inherent  to each myoblast. Both mecha- 
nisms have been elegantly demonstrated to contribute to the 
generation of oligodendrocytes and type-2 astrocytes from 
0-2A progenitor cells during the development of the rat optic 
nerve. The differentiation of the bipotential glial progenitor 
into oligodendrocytes is timed by a biological clock intrinsic 
to the progenitor cell (Raft et al.,  1985; Temple and Raft, 
1986).  However,  an  extrinsic  factor  (Richardson  et  al., 
1988) is necessary to drive this clock. In contrast, the deci- 
sion to differentiate into type 2 astrocytes is not intrinsic to 
the progenitor cell, but is apparently controlled by an induc- 
ing factor, ciliary neurotrophic factor (Hughes et al., 1988). 
Cell-intrinsic mechanisms also were found to play a role in 
the generation of cell diversity in erythroid cells. Fetal and 
adult erythropoietic stem cells differ in their potential to ex- 
press developmental  stage-specific hemoglobins  (Papayan- 
nopoulou et al.,  1977,  1979).  Experiments  in which stem 
cells of fetal  sheep  were transplanted  to  an  adult  animal 
demonstrated that the pattern of hemoglobin production was 
determined by the gestational ages of the fetal donor cells, 
suggesting that the control of fetal to adult globin switching 
was cell-autonomous (Wood et al.,  1985). 
We tested the hypothesis that a cell-intrinsic  mechanism 
controlled the switch from early- to late-type myoblasts. To 
this end, early myoblasts were propagated for at least 25 dou- 
blings in culture over a period of more than 3 wk, a period 
twofold longer than that during which the myoblast popula- 
tion changed in vivo, yet a progression to neonatal MyHC 
was still not observed in FM. Thus, it appears unlikely that 
a  division-dependent  clock controls the conversion of the 
week 7 to the week 9 myoblast phenotype; instead environ- 
mental cues may be critical. 
One possible extrinsic cue that could convert the early to 
late myoblasts is irmervation, which begins during secondary 
myogenesis (Fidzianska, 1980b). However, morphogenic fac- 
tors produced locally in the tissue or blood-borne factors 
could also play a role. An alternate possibility which cannot 
be ruled out is that week 7 myoblasts do not convert to week 
9 type myoblasts, but are replaced by them. In this case, at 
week 7 the late-stage myoblasts would comprise <1% of the 
total clonable population, whereas by week 9 it would have 
grown to comprise 99%. A possible mechanism for this re- 
placement might involve differential responsiveness between 
the early and late myoblast populations to growth and dif- 
ferentiation factors present in the organism at these stages. 
The disappearance of week 7 myoblasts may be due to apop- 
tosis, a mechanism for specific elimination of cells which has 
been shown to occur in a diversity of tissues (Raft,  1992). 
We, like White et al. (1975 and Cossu et al. (1985), observed 
that week 7 myotubes do not survive under serum-free condi- 
tions, indicating that expression of neonatal MyHC may not 
be the only feature distinguishing week 7 and week 9 cells. 
It  should  now be possible using  retroviral  marking  tech- 
niques (Hughes and Blau,  1990) to distinguish among these 
possibilities and determine the cellular origin of primary and 
secondary fibers in vivo. 
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